Treatment for postmenopausal osteoporosis

Description:

Asimical® 150 contains Ibandronic acid (such as Ibandronate sodium monohydrate) as the active ingredient, which is an amino bisphosphonate with a powerful inhibitory action on bone resorption; which is used as a prophylactic and treatment of postmenopausal osteoporosis, reducing the risk of fractures, since it inhibits the activity of osteoclasts, reducing bone resorption and raising bone volume levels, which is important for a net gain in bone mass. Asimical® 150 has an elimination half-life from the bone surface of several weeks, which allows a monthly dose, with an effect comparable to the daily dose.

Indications:

Asimical® 150 is indicated for the treatment and prevention of osteoporosis in postmenopausal women and for those who wish, through a clinical result, to maintain bone mass and reduce the risk of future fractures.

Active ingredient:

Ibandronic Acid